![](/img/cover-not-exists.png)
299 BASELINE CHARACTERISTICS ASSOCIATED WITH PRESCRIPTION OF RIBAVIRIN >800 MG/DAY AMONG G2/3 PATIENTS PRESCRIBED PEGINTERFERON ALFA-2A (40KD) FROM REAL-WORLD PATIENT COHORTS: INTERIM RESULTS FROM PROPHESYS
M.L. Shiffman, P. Ferenci, T. Hassanein, M. Curescu, C. Coppola, J. Pruthi, R. Aires, G. Lengyel, S. Pol, D. Nelson, D. Messinger, A. Tietz, G.M. DusheikoVolume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60301-7
File:
PDF, 115 KB
english, 2010